Article

jdsupra.comjdsupra.com on 2019-11-26 20:15

Galderma Labs L.P. v. Teva Pharms. USA, Inc.

THE ASSERTED CLAIMS OF 1% IVERMECTIN FORMULATION ARE INVALID ON THE BASIS OF ANTICIPATION IN LIGHT OF A PRIOR ART REFERENCE THAT TEACHES APPLICATION ...

Related news